NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/13/2022
Back to search
Official data from USPTO
NEOLEUKIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEOLEUKIN
ST13
US500000088424211Class
5, 42, 44
Filing
88424211
Registration
6925228
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
12/13/2022
Trademark type
Word
Nice classes
5, 42, 44
Filing date
05/10/2019
Registration date
12/13/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2022
Last transaction
12/13/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-08-00
First use in commerce
2021-08-00
Drawing code
4
Owner type
03
Owner location
SEATTLE, WA, US
Examiner
GUROK, GALINA
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NEOLEUKIN THERAPEUTICS, INC.
Neoleukin Corporation per assignment recorded at reel/frame 6788/0849
NEOLEUKIN THERAPEUTICS, INC.
Representatives
Connie Ellerbach FENWICK & WEST LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical preparations for the treatment and use in oncology; pharmaceutical preparations and substances for the prevention and treatment of cancer; biological preparations for the treatment and prevention of cancer
Class 42
Research and development of pharmaceuticals for the treatment and prevention of cancer; scientific research for medical purposes in the field of cancer
Class 44
Providing health information in the field of autoimmuneinflammatory and infectious diseases and disorderscancer prevention and treatment; providing a website featuring information in the field of diagnosis and treatment of autoimmuneinflammatory and infectious diseases and disorderscancer
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/13/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/08/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/07/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/01/2022
IUAF
USE AMENDMENT FILED
10/26/2022
EISU
TEAS STATEMENT OF USE RECEIVED
10/26/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/26/2022
EX5G
SOU EXTENSION 5 GRANTED
04/25/2022
EXT5
SOU EXTENSION 5 FILED
04/22/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/22/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/30/2021
EX4G
SOU EXTENSION 4 GRANTED
09/28/2021
EXT4
SOU EXTENSION 4 FILED
09/28/2021
EEXT
SOU TEAS EXTENSION RECEIVED
09/28/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/22/2021
EX3G
SOU EXTENSION 3 GRANTED
04/20/2021
EXT3
SOU EXTENSION 3 FILED
04/20/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/20/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/27/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/21/2020
EX2G
SOU EXTENSION 2 GRANTED
10/19/2020
EXT2
SOU EXTENSION 2 FILED
10/19/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/19/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/28/2020
EX1G
SOU EXTENSION 1 GRANTED
04/27/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/27/2020
EXT1
SOU EXTENSION 1 FILED
04/17/2020
EEXT
SOU TEAS EXTENSION RECEIVED
04/17/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/29/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/03/2019
PUBO
PUBLISHED FOR OPPOSITION
09/03/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/14/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/26/2019
DOCK
ASSIGNED TO EXAMINER
07/26/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/24/2019
NWAP
NEW APPLICATION ENTERED
05/14/2019
Continuous trademark protection
Get notified about every new filing that threatens NEOLEUKIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.